US 11,746,089 B2
Compounds and methods for treating alcohol disorder
Lewis Feldberg, Montclair, NJ (US); Akram Sabouni, Cary, NC (US); and Vincent Wing-Fai Tai, Cary, NC (US)
Assigned to SOPHROSYNE PHARMACEUTICALS LIMITED, George Town (KY)
Filed by SOPHROSYNE PHARMACEUTICALS LIMITED, George Town (KY)
Filed on Jan. 10, 2023, as Appl. No. 18/152,375.
Application 18/152,375 is a continuation of application No. 17/538,250, filed on Nov. 30, 2021.
Claims priority of provisional application 63/202,424, filed on Jun. 10, 2021.
Claims priority of provisional application 63/119,211, filed on Nov. 30, 2020.
Prior Publication US 2023/0159461 A1, May 25, 2023
Int. Cl. C07D 211/46 (2006.01); C07C 333/04 (2006.01); C07C 333/20 (2006.01); A61P 25/32 (2006.01)
CPC C07D 211/46 (2013.01) [A61P 25/32 (2018.01); C07C 333/04 (2013.01); C07C 333/20 (2013.01)] 10 Claims
 
1. A pharmaceutical composition comprising a compound having a formula of

OG Complex Work Unit Chemistry
or a pharmaceutically acceptable salt solvate thereof, in an enantiomeric excess of at least 95%.